miR-3651 Participates in the Growth Cycle of Hepatocellular Carcinoma Cells and Promotes the Malignant Metastasis via the PI3K/AKT/mTOR Signalling Pathway

OBJECTIVE: Hepatocellular carcinoma (HCC) shows a growing incidence over the past few years, and clinical efforts are made to search for more effective novel diagnosis and therapy regimen for it to improve its outcome. This study probed into the association of miR-3651 with the PI3K/AKT/mTOR pathway...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yawei, Hu, Litian, Liu, Qinqiang, Ye, Jing, Zhang, Jianping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553513/
https://www.ncbi.nlm.nih.gov/pubmed/36245984
http://dx.doi.org/10.1155/2022/5744999

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553513/
https://www.ncbi.nlm.nih.gov/pubmed/36245984
http://dx.doi.org/10.1155/2022/5744999

Ejemplares similares